Hemoglobin A, Glycosylated
Research News and Information

Saturday, November 21, 2009

Prediction of proliferative diabetic retinopathy with hemoglobin level.

30 Oct 2009 OBJECTIVE: To investigate the role of hemoglobin (HGB) level in predicting proliferative diabetic retinopathy (PDR). METHODS: We assessed 426 individuals without PDR at baseline (213 men; 213 women) from the Pittsburgh Epidemiology of Diabetes ... Read more...

Improving chronic care of type 2 diabetes using teams of interprofessional learners.

30 Oct 2009 PURPOSE: To improve the care and outcomes of adult patients with type 2 diabetes by teaching interprofessional teams of learners the principles and practices of the Improving Chronic Illness Care Model. METHOD: The study population consisted of 384 ... Read more...

A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).

30 Oct 2009 PURPOSE: To study glycemic control and hypoglycemia development upon initiation of insulin through a self-titration schedule in a 24-week trial, conducted with 4875 insulin-naïve patients with poorly controlled type 2 diabetes, predominantly in a ... Read more...

Latest indexed articles for 'Hemoglobin A, Glycosylated'

These are the very latest articles for this heading:

• Prediction of proliferative diabetic retinopathy with hemoglobin level. 30 Oct 2009
• Improving chronic care of type 2 diabetes using teams of interprofessional learners. 30 Oct 2009
• A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). 30 Oct 2009
• The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. 24 Oct 2009
• Three-year efficacy of complex insulin regimens in type 2 diabetes. 20 Oct 2009
• Optimal insulin treatment in type 2 diabetes. 20 Oct 2009
• Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. 11 Oct 2009
• Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. 10 Oct 2009
• Early progression of the autonomic dysfunction observed in pediatric type 1 diabetes mellitus. 3 Oct 2009
• The diabetes mellitus medication choice decision aid: a randomized trial. 26 Sep 2009
• Patient-centered care: what is the best measuring stick? 26 Sep 2009
• A case of discordant HbA(1c): a method-dependent error. 19 Sep 2009
• Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. 19 Sep 2009
• Glycaemic control in hospitalised diabetic patients at the University Hospital Basel in 2002 and in 2005. 17 Sep 2009
• Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. 17 Sep 2009
• Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. 14 Sep 2009
• Controlling the complications of diabetes: it's about the sugar. 13 Sep 2009
• Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. 9 Sep 2009
• Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. 8 Sep 2009
• Quality of care of diabetes mellitus type II patients in Iran. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Hemoglobin A, Glycosylated'

Definition: Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.

Registry Number: 0

Descriptor UI: D006442

Alternative terms: Hemoglobin A, Glycosylated; Hb A1a+b; Hb A1c; HbA1; Glycosylated Hemoglobin A; Hb A1; Glycohemoglobin A; Hemoglobin A(1); Hemoglobin, Glycosylated A1b; A1b Hemoglobin, Glycosylated; Glycosylated A1b Hemoglobin; Hb A1b; Hemoglobin, Glycosylated A1a-1; A1a-1 Hemoglobin, Glycosylated; Glycosylated A1a-1 Hemoglobin; Hemoglobin, Glycosylated A1a 1; Hb A1a-1; Hb A1a-2; Hemoglobin, Glycosylated; Glycosylated Hemoglobin; Glycated Hemoglobins; Hemoglobins, Glycated;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D09.408.375; D12.776.124.400.405.440; D12.776.422.316.762.380.440;

History Note: 82

Technical Notes: urine: coord IM with HEMOGLOBINURIA (IM); DF: note short X refs